Samir Gharib
2021
In 2021, Samir Gharib earned a total compensation of $2.4M as President and Chief Financial Officer at SPRUCE BIOSCIENCES, a 200% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $100,000 |
|---|---|
| Option Awards | $1,156,295 |
| Salary | $380,000 |
| Stock Awards | $744,000 |
| Total | $2,380,295 |
Gharib received $1.2M in option awards, accounting for 49% of the total pay in 2021.
Gharib also received $100K in non-equity incentive plan, $380K in salary and $744K in stock awards.
Rankings
In 2021, Samir Gharib's compensation ranked 5,348th out of 12,406 executives tracked by ExecPay. In other words, Gharib earned more than 56.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,348 out of 12,406 | 57th |
Division Manufacturing | 2,248 out of 5,492 | 59th |
Major group Chemicals And Allied Products | 978 out of 2,368 | 59th |
Industry group Drugs | 870 out of 2,089 | 58th |
Industry Pharmaceutical Preparations | 624 out of 1,536 | 59th |
Source: SEC filing on April 7, 2022.
Gharib's colleagues
We found three more compensation records of executives who worked with Samir Gharib at SPRUCE BIOSCIENCES in 2021.
News
SPRUCE BIOSCIENCES CEO Javier Szwarcberg's 2023 pay falls 52% to $2.2M
April 5, 2024
SPRUCE BIOSCIENCES CEO Javier Szwarcberg receives $4.5M in 2022
April 5, 2023
SPRUCE BIOSCIENCES CEO Richard King's 2021 pay jumps 107% to $5.1M
April 7, 2022
SPRUCE BIOSCIENCES CEO Richard King's 2020 pay jumps 349% to $2.5M
April 2, 2021